版本:
中国

BRIEF-Kempharm Inc says presents clinical data for opioid prodrug candidates

March 16 Kempharm Inc

* Kempharm Inc says presents clinical data for opioid prodrug candidates at American Academy of Pain Medicine's annual meeting

* Kempharm - in trial, observed peak hydrocodone plasma concentration was 36.0% lower, and total hydrocodone exposures and AUC were 20.3% and 19.5% lower, respectively Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐